K-numberK242607
Device nameScanDiags Ortho L-Spine MR-Q
ApplicantScandiags AG
Product codeQIH
Device classClass II
Decision dateFeb 21, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

ScanDiags Ortho L-Spine MR-Q is a software tool that processes previously-acquired DICOM lumbar spine MRI images to automatically segment and measure anatomical structures (vertebral bodies, intervertebral discs, neuroforamina, thecal sac) using deep learning. It generates quantitative measurements and PDF reports for radiologist review and approval, intended for use in hospitals and medical institutions on patients aged 22 and above.

Technological characteristics

Both subject and predicate devices are Class II medical image management and processing systems using MRI modality for lumbar spine analysis. The subject device uses supervised deep convolutional neural networks (DCNN) for both classification and segmentation, while the predicate uses deep convolutional image-to-image neural networks. Both provide semi-automatic segmentation, area/distance measurements, and PDF reports requiring human radiologist interpretation; the subject device measures slightly more parameters (spinal canal area, angle, biconcave height losses) but follows the same operational principles.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

The subject device is substantially equivalent because it shares the same intended use (quantitative measurement of lumbar spine structures from MRI), same regulatory classification and product code (21 CFR 892.2050, QIH, Class II), and operates on the same principles as the predicate. Performance validation across 100 patient studies from multiple MRI manufacturers demonstrated acceptable measurement accuracy (ICC 0.74–0.95, Dice scores 0.86–0.95, MAE <1.3 mm) comparable to inter-radiologist agreement, with subgroup analyses confirming consistent performance across demographics and imaging parameters. The technological differences (refined neural network architecture, expanded measurement set) do not raise new safety or efficacy concerns since both require radiologist review and neither produces diagnostic recommendations.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →